| Cash Flow | 2025-03-31 |
|---|---|
| Net loss | -560,232 |
| Issuance of common stock for services | 56,100 |
| Prepaid | -10,000 |
| Inventories | 214,107 |
| Deferred revenue | 0 |
| Accrued compensation - officers | 0 |
| Accrued liabilities | 54,553 |
| Accounts receivable | -290,413 |
| Accounts payable | -3,630 |
| Accounts payable - related parties | 0 |
| Depreciation and amortization | 360 |
| Debt discount amortization | 0 |
| Issuance of warrants for services | -394,999 |
| Customer deposits | -120,942 |
| Net cash used in operating activities | -92,486 |
| Note receivable | 0 |
| Net cash used in investing activities | 0 |
| Repayments of notes payable | 31,865 |
| Repayments of note payable shareholder | 0 |
| Net borrowings (repayments) under lines of credit | 0 |
| Proceeds from issuance of note payable shareholder | 12,000 |
| Proceeds from issuance of common stock | 50,000 |
| Net cash provided by financing activities | 30,135 |
| Net increase (decrease) in cash | -62,351 |
US NUCLEAR CORP. (UCLE)
US NUCLEAR CORP. (UCLE)